Market revenue in 2022 | USD 11,816.3 million |
Market revenue in 2030 | USD 32,833.0 million |
Growth rate | 13.6% (CAGR from 2022 to 2030) |
Largest segment | Contract manufacturing |
Fastest growing segment | Quality Assurance |
Historical data | 2018 - 2021 |
Base year | 2022 |
Forecast period | 2023 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Quality Assurance, Regulatory Affairs Services, Product Design and Development Services, Product Testing & Sterilization Services, Product Implementation Services, Product Upgrade Services, Product Maintenance Services, Contract Manufacturing |
Key market players worldwide | SGS AG, Labcorp Holdings Inc, Eurofins Scientific SE, Pace Analytical Services, Intertek Group PLC, Wuxi AppTec Co Ltd, Sotera Health Co Ordinary Shares, Charles River Laboratories International Inc, Medical Device Testing Services, FREYR Battery Inc, PAREXEL, Accell, Genpact Ltd, Criterium Inc., Promedica International, Medpace Holdings Inc, Icon PLC, IQVIA Holdings Inc, Integer Holdings Corp, Tecomet, Jabil Inc, Flex Ltd, Celestica Inc Ordinary Shares (Subordinate Voting), Sanmina Corp, Plexus Corp, Molex, Steris PLC, West Pharmaceutical Services Inc, NAMSA, TUV SUD, RJR Consulting, Mandala International, Global Regulatory Partners, Emergo Group, BioTeknica Engineering & Regulatory Services |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to medical device outsourcing market will help companies and investors design strategic landscapes.
Contract manufacturing was the largest segment with a revenue share of 54.74% in 2022. Horizon Databook has segmented the China medical device outsourcing market based on quality assurance, regulatory affairs services, product design and development services, product testing & sterilization services, product implementation services, product upgrade services, product maintenance services, contract manufacturing covering the revenue growth of each sub-segment from 2018 to 2030.
China is one of the most technologically advanced countries, which significantly contributes to the healthcare industry of the region. In addition, rise in the geriatric population and presence of a large fraction of the population belonging to the middle-income group increases the demand for innovative & cost-effective medical equipment, which is expected to attract major medical device companies to this region.
The low cost of labor is one of the key factors, and outsourcing clinical research services in China is cost-effective. Owing to this reason, the number of clinical research studies in China is expected to increase. This is expected to boost competition in the market in China.
For instance, in March 2023, GE Healthcare established a long-term joint venture with Sino pharm as part of its strategy to further penetrate the medical device market in China. China held the second-largest share of the overall medical device outsourcing market owing to the increase in the number of collaborations of industry players with Original Equipment Manufacturers (OEMs) present in this region.
Horizon Databook provides a detailed overview of country-level data and insights on the China medical device outsourcing market , including forecasts for subscribers. This country databook contains high-level insights into China medical device outsourcing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account